Don Miller, Senior Content Manager at MarketBeat About The Editor Don MillerSenior Content ManagerExperienceDon Miller has been a senior content manager for MarketBeat since 2017.Don serves as the editorial supervisor and oversees the overall production, from idea generation to publication. He keeps an eye on our network of news websites and is one to help facilitate the creation of content and manage the freelance writers we work with. Building, creating and growing a team is the most inspiring part of his job. He brings a very diverse work experience to the table. From seminary, ministry and government to internet marketing and freelance writing; Don has seemingly done it all. He has even written for ESPN once upon a time.Learn About MarketBeat's Editorial Guidelines and Standards PolicyLatest Articles Reviewed by Don MillerOctober 7, 2024 7:01 AM ET3 Technology Stocks Set to Outperform This QuarterGabriel Osorio-MazilliThere are three stocks that stand out in the computer software industry to show investors where the next wave of double-digit upside might come from NYSE:SNASDAQ:CSGPNASDAQ:CYBRRead 3 Technology Stocks Set to Outperform This QuarterOctober 7, 2024 6:35 AM ETJD.com: The Cream Rises to the Top in the China Stimulus BoomJea YuJD.com Inc. (NASDAQ: JD) is one of the better fundamentally sound stocks that justifies a surge, as they say the cream rises to the top. NASDAQ:JDNASDAQ:AMZNNYSE:BABARead JD.com: The Cream Rises to the Top in the China Stimulus BoomOctober 4, 2024 7:56 AM ETHas Costco Stock Run Its Course for Now?Leo MillerCostco stock has had a great 2024, but its rise has slowed significantly. However, Wall Street is raising price targets as the stock declines.NYSEARCA:XLPNYSE:TGTNYSE:KRRead Has Costco Stock Run Its Course for Now?October 4, 2024 6:46 AM ETInsiders Are Betting Big on These 2 StocksThomas HughesInsider buying in Matador Resources and V2X, Inc. highlights a deep value opportunity in two growing companies that investors should not ignore. NYSE:VVXNYSE:MTDRRead Insiders Are Betting Big on These 2 StocksOctober 3, 2024 9:37 AM ETIs NVIDIA Stock in a Correction or Consolidation? Gabriel Osorio-MazilliThere is a warning sign coming out of the Nvidia stock chart today, investors should watch out for the deteriorating fundamentals in the semiconductor spaceNASDAQ:NVDARead Is NVIDIA Stock in a Correction or Consolidation? October 3, 2024 6:32 AM ETThe Race for Space: 3 Small Cap Space Stocks to BuyRyan HassonSeveral small-cap stocks are vying for dominance in the aerospace and defense industry, particularly in the rapidly growing space race.NASDAQ:LUNRNASDAQ:RKLBNYSE:RDWRead The Race for Space: 3 Small Cap Space Stocks to BuyOctober 2, 2024 6:50 AM ET3 High-Yield Dividend Stocks Analysts Favor as Rates DropRyan HassonHigh-yield dividend stocks are gaining attention as interest rates drop following the Federal Reserve's recent 50-basis-point rate cut.NASDAQ:KHCNYSE:TFCNYSE:CVXRead 3 High-Yield Dividend Stocks Analysts Favor as Rates DropOctober 2, 2024 6:35 AM ET3 Momentum Trades Too Good Pass UpLeo MillerCheck out these three stocks each up over 60% in the past twelve months. Their strong paths for growth can help keep their momentum stories going.NYSE:DELLBATS:MTUMNYSEARCA:SPYRead 3 Momentum Trades Too Good Pass UpSeptember 30, 2024 6:59 AM ETSalesforce Stock Gets a Wall Street Boost, Cloud Businesses Back?Gabriel Osorio-MazilliAnalysts have found a new reason to boost Salesforce stock, and investors would benefit from learning what that reason is for their own considerationNYSE:CRMNASDAQ:WDAYNASDAQ:ADBERead Salesforce Stock Gets a Wall Street Boost, Cloud Businesses Back?September 30, 2024 6:40 AM ET3 Multi-Bagger Stocks to Buy Now for Explosive GrowthGabriel Osorio-MazilliThree stocks could become what some call multi-baggers in the coming years through their high margins and returns on invested capital rates NASDAQ:AMZNNASDAQ:MELINYSE:BABARead 3 Multi-Bagger Stocks to Buy Now for Explosive GrowthSeptember 30, 2024 6:22 AM ETCapricor Therapeutics Is Up Over 100%, Could Rise Even HigherJea YuCapricor Therapeutics Inc. (NASDAQ: CAPR) is a biotechnology firm focused on developing cell and exosome-based treatments for rare diseases like iomyopathyNASDAQ:CAPRNASDAQ:SRPTNASDAQ:PEPGRead Capricor Therapeutics Is Up Over 100%, Could Rise Even HigherSeptember 30, 2024 6:15 AM ETCiti Analysts Turn More Bullish on Walmart Stock: Time to Buy?Ryan HassonWalmart (NYSE: WMT) has surged over 51% YTD, outperforming its sector and the broader market, with Citi analysts recently upgrading their bullish outlook.NYSE:WMTRead Citi Analysts Turn More Bullish on Walmart Stock: Time to Buy? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
